0001214659-19-000461.txt : 20190122 0001214659-19-000461.hdr.sgml : 20190122 20190122190043 ACCESSION NUMBER: 0001214659-19-000461 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190117 FILED AS OF DATE: 20190122 DATE AS OF CHANGE: 20190122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHEN ISAN CENTRAL INDEX KEY: 0001586218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 19536306 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-43744.xml PRIMARY DOCUMENT X0306 4 2019-01-17 0001576263 Mirati Therapeutics, Inc. MRTX 0001586218 CHEN ISAN C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Medical Officer Common Stock 34966 D Common Stock 110 I By Chen Living Trust Option Grant (Right to Buy) 64.14 2019-01-17 4 A false 60000 0 A 2029-01-16 Common Stock 60000 60000 D Includes 384 shares acquired under the ESPP Purchase on 11/30/18. 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested. /s/ Vickie Reed, Attorney-in-Fact 2019-01-22